Whether these abnormal CBF regulation mechanisms contribute to a 1.5 times higher odds of developing a stroke for PAH patients remains to be addressed (Shah, Sutaria, & Vyas, 2019). The gene discussed is CEBPZ; the disease is pulmonary arterial hypertension.